The New Jersey Innovation Institute (NJII) and Choose New Jersey will be hosting a virtual ribbon cutting, tour and panel discussions to mark the opening of BioCentriq™ on Thursday, October 29 at 2:30pm.
RSVP to attend here.
BioCentriq is NJII’s cell and gene therapy development and clinical manufacturing center located on the campus of the New Jersey Institute of Technology (NJIT) in Newark, NJ.
The event will be emceed by Jose Lozano, president and CEO of Choose New Jersey. Opening remarks will be made by Joel Bloom, Ph.D., president of NJIT, New Jersey Governor Phil Murphy, Robert Cohen, president digital, robotics, and enabling technology at Stryker and Simon Nynens, CEO of NJII.
Dr. Peter Marks, Ph.D., director of the center for biologics evaluation and research (CBER) at the U.S. Food and Drug Administration (FDA) will speak about the critical need for additional capacity for the development and manufacturing of biologics and the complex path to clinical trials for vaccines and cell and gene therapies.
Haro Hartounian, Ph.D. and SVP and GM of the Biopharma Division will provide a more detailed view of the new center for the development and clinical manufacturing of cell and gene therapies and the work of the Biopharma division at NJII. He will also premier a pre-recorded virtual tour of the facility and take questions about BioCentriq™.
Dr. Hartounian will then lead a panel discussion on the future of cell and gene therapy manufacturing with Kelvin H. Lee, Ph.D., director of the National Institute for Innovation in Manufacturing (NIIMBL), Janet Lynch Lambert, CEO of the Alliance for Regenerative Medicine and Greg Russotti, Ph.D., chief technology officer of Century Therapeutics, LLC.
The event will conclude with a panel discussion with leaders who can describe the resources available to companies who bring their cell and gene therapy projects and businesses to New Jersey.
Panelists include Debbie Hart, president & CEO of BioNJ, Jose Lozano, president & CEO of Choose New Jersey, Kathleen Coviello, executive vice president for Technology, Life Sciences & Entrepreneurship at the New Jersey Economic Development Authority (NJEDA) and Kevin D. Belfield, Ph.D., dean, College of Science & Liberal Arts, NJIT.
The event takes place on Thurs Oct 29th from 2:30 p.m. to 3:30 p.m. EDT.
Visit https://www.choosenj.com/webinar/first-look-at-biocentriq/ to learn more and RSVP to attend.